Thermo Fisher Scientific Gibco CTS OpTmizer Pro Serum Free Media (SFM)

Wednesday, 10 February, 2021 | Supplied by: Thermo Fisher Scientific



Thermo Fisher Scientific has developed a medium for the development and expansion of human T lymphocytes (T cells) for cell therapy developers using allogeneic workflows. The Gibco CTS OpTmizer Pro Serum Free Media (SFM) is a media solution that targets the metabolism of healthy donor cells, making it suitable for use in the production of allogeneic, off-the-shelf cell therapies.

In contrast to autologous cell therapies, which are produced using a patient’s own cells, allogeneic cell therapies are derived from healthy donor tissue, potentially enabling more scalable cell therapy manufacturing. The SFM enhances donor T cell proliferation, maintains central memory T cells further into expansion and delays effector differentiation of healthy donor T cells, resulting in fast production of central memory cells.

The product packaging is suitable for closed systems and is manufactured in conformity with current Good Manufacturing Practice (cGMP) standards. The serum-free media is ready to use and compatible with automated and long workflows, providing a consistent formulation designed to maintain cell quality and increase the efficacy of cell-based therapies.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

ProSci cytokine storm research antibodies and proteins

The cytokine storm is still a relatively recent discovery, scientifically speaking, and is...

Thermo Fisher Scientific Gibco Human Plasma-like Medium (HPLM)

The cell culture medium mimics the metabolic profile of human plasma and is designed to provide...

EXBIO ApoFlowEx FITC Kit for apoptosis detection

The kit consists of fluorescently labelled annexin V and propidium iodine for flow cytometry...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd